Transcarent To Acquire Accolade (ACCD) for $7.03 per share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
January 8, 2025 12:07 PM ESTTruist Securities analyst Jailendra Singh reiterated a Buy rating and $7.50 price target on Accolade Inc. (NASDAQ: ACCD)
The analyst comments "Why We Like the Deal. We have long viewed mergers between digital health companies as being accretive in value proposition for end-markets as opposed to entities such as... More



